Bioanalytical Services

Offering support for your clinical trials program

Bioanalysis Optimized: Accurate, Reliable, and Customized Bioanalytical Assays

ACM Bioanalytical Services, can help optimize your drug development program and ensure that you have the technical insight needed to successfully complete your bioanalytical studies. Our chemists have the expertise and flexibility to assist you with complex assay method development and validation for the quantification of drugs, metabolites, and biomarkers in biological samples.

Pharmaceutical research and development is a complex and demanding endeavor. While the pace and scope of scientific information accumulates rapidly, most clinical trials take approximately seven years to complete. However, on average less than 12% of drugs entering clinical testing are approved. To increase the likelihood of success, it is critical to connect with experts that understand the complexities of the industry.

ACM is your strategic partner. We provide sound scientific strategies that enable you to obtain the information that you need to make timely, data-driven decisions about the direction of your preclinical or clinical trial program.

Bioanalytical LCMSMS

 Bioanalytical Services and Support

To assist you in advancing your development program, ACM partners with you to generate a robust data package and provides expert guidance to help you navigate stringent regulatory requirements. With over 20 years of experience, our scientists are adept at supporting small molecule and metabolite pharmacokinetic studies and can assist with both your preclinical and clinical trials programs.

Explore Our Services

  • Pharmacokinetics

    Pharmacokinetic (PK) Analysis

    Quantitative bioanalysis of drugs and their metabolites in a variety of biological matrices

    Learn More
  • Pharmacodynamics

    Pharmacodynamic (PD) Biomarker Analysis

    Detection of endogenous biomarkers at low levels in biological fluids

    Learn More
  • Smoking Icon

    Smoking and Nicotine Research

    Experience in smoking and nicotine replacement therapy analysis and product development

    Learn More
  • Cannabinoid

    Cannabinoid Testing

    Validated assay techniques to determine the bioavailability of various cannabinoids, and their metabolites, in a variety of different formulations and routes of administration

    Learn More
  • Antibody Icon

    Large Molecule Bioanalysis via Ligand Binding Assays

    Determine PK/TK concentrations of monoclonal antibodies, proteins, peptides, biosimilars, oligonucleotides and determine levels of anti-drug antibodies and neutralizing antibodies in biological samples

    Learn More

New Name, Same Great Actionable Insights

You may have noticed that the name of ABS Laboratories has changed to ACM Bioanalytical Services. This is the culmination of a strategic growth initiative and we couldn't be more thrilled to share it with you. Our rebrand will not have any affect on current clients and we invite you to explore some documentation on the update below.
Contact Us for Questions

Statement of Compliance

An inspection for compliance with the Principles of Good Laboratory Practice was carried our lab in the UK and we meet all necessary compliance standards.
Read Now

Client Letter

Tom Mueller, ACM's Chief Commercial Officer, shares the exciting news of our rebrand in a letter to our clients.
Read Now

bioanalytical testing

We’re Your Dedicated Partner

Your project is our top priority. ACM Global Laboratories is committed to delivering accurate and reproducible results and reliable services to help promote your drug development program. We provide these additional services and benefits:
ACM clinical partner
Full-method development and method transfer capabilities
ACM clinical partner
Development of customized assays to support preclinical and clinical research and development initiatives
ACM clinical partner
Early-stage discovery and regulated lead candidate sample analysis
ACM clinical partner
Expertise in state-of-the-art methods that meet the European Medicines Agency (EMA) and the U.S. Federal Drug Administration (FDA) Guidelines, and other international regulatory agencies


Effective 09 November 2021 the CAP director for ACM UK was transitioned from Kevin Troth to Dean Brown. ACM UK CAP accreditation is uninterrupted.
Paper Icon
Good Laboratory Practice (GLP)
Clinical Trials Partner
Good Clinical Practice (GCP)
Magnifying Glass
Regularly inspected by the MHRA since 1997

Advanced Equipment and Matrices

Technically Equipped to Deliver Accurate, Expert Analysis

We bring a scope of leading-edge technologies and expertise to studies worldwide. Our laboratories maintain state-of-the-art instrumentation and methodologies that include:



  • SCIEX Triple Quad™6500(LC-MS/MS) Systems. Six Liquid Chromatograph – Two Dimensional Mass Spectrometer Instruments. This platform provides significantly higher sensitivity and specificity than common UV detectors.
  • Ultra-high performance liquid chromatography (UHPLC) capability. Provides a dramatic increase in resolution, speed, and sensitivity in liquid chromatography allowing for greater accuracy and overall success.
  • 96-well plate format
  • Automation with 96-well pipetting stations. This format has the capacity to support high-throughput bioanalysis experiments.


Our laboratory protocols support bioanalytical studies involving a number of different matrices, including:

  • Plasma & serum
  • Saliva & urine
  • Feces
  • Various tissues
  • Dried blood spots/VAM® volumetric absorptive micro-sampling device
clinical trial equipment

Download Additional Resources

cannabinoid research image

Cannabinoid Expertise

Download this helpful PDF to learn more about our services.

Download Now
nicotine research image

Nicotine and Smoking Research

Download this helpful PDF to learn more about our services.

Download Now